Evidence map›Paper›PMID 35749444›Full record

SynthesisPloS one2022

Fatigue in incident peritoneal dialysis and mortality: A real-world side-by-side study in Brazil and the United States.

Murilo Guedes, Liz Wallim, Camila R Guetter, Yue Jiao, Vladimir Rigodon, Chance Mysayphonh, Len A Usvyat, Pasqual Barretti, Peter Kotanko, John W Larkin and 3 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Sleep-Related Disorders in Patients with CKD and Kidney Transplant Recipients.Clinical journal of the American Society of Nephrology : CJASN · 2025
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Murilo GuedesPontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.ORCID 0000-0002-3495-852X
Liz WallimPontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.
Camila R GuetterJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America.ORCID 0000-0002-7918-4580
Yue JiaoFresenius Medical Care Global Medical Office, Waltham, MA, United States of America.ORCID 0000-0002-5705-9789
Vladimir RigodonPontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.ORCID 0000-0002-3960-9935
Chance MysayphonhPontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.
Len A UsvyatFresenius Medical Care Global Medical Office, Waltham, MA, United States of America.ORCID 0000-0003-2745-1429
Pasqual BarrettiUniversidade do Estado de São Paulo, Botucatu, SP, Brazil.ORCID 0000-0003-4979-4836
Peter KotankoRenal Research Institute, New York, NY, United States of America.ORCID 0000-0003-4373-412X
John W LarkinFresenius Medical Care Global Medical Office, Waltham, MA, United States of America.ORCID 0000-0001-8873-8971
Franklin W MadduxFresenius Medical Care AG & Co. KGaA, Global Medical Office, Bad Homburg, Germany.ORCID 0000-0003-1395-2011
Roberto Pecoits-FilhoPontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.ORCID 0000-0002-0255-6710
Thyago Proenca de MoraesPontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil.ORCID 0000-0002-2983-3968
Pontifícia Universidade Católica do Paraná · BRFresenius Medical Care (United States) · USFresenius Medical Care (Germany) · DEJohns Hopkins University · USRenal Research Institute · USUniversidade Estadual Paulista (Unesp) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe tested if fatigue in incident Peritoneal Dialysis associated with an increased risk for mortality, independently from main confounders.

methodsWe conducted a side-by-side study from two of incident PD patients in Brazil and the United States. We used the same code to independently analyze data in both countries during 2004 to 2011. We included data from adults who completed KDQOL-SF vitality subscale within 90 days after starting PD. Vitality score was categorized in four groups: >50 (high vitality), ≥40 to ≤50 (moderate vitality), >35 to <40 (moderate fatigue), ≤35 (high fatigue; reference group). In each country's cohort, we built four distinct models to estimate the associations between vitality (exposure) and all-cause mortality (outcome): (i) Cox regression model; (ii) competing risk model accounting for technique failure events; (iii) multilevel survival model of clinic-level clusters; (iv) multivariate regression model with smoothing splines treating vitality as a continuous measure. Analyses were adjusted for age, comorbidities, PD modality, hemoglobin, and albumin. A mixed-effects meta-analysis was used to pool hazard ratios (HRs) from both cohorts to model mortality risk for each 10-unit increase in vitality.

resultsWe used data from 4,285 PD patients (Brazil n = 1,388 and United States n = 2,897). Model estimates showed lower vitality levels within 90 days of starting PD were associated with a higher risk of mortality, which was consistent in Brazil and the United States cohorts. In the multivariate survival model, each 10-unit increase in vitality score was associated with lower risk of all-cause mortality in both cohorts (Brazil HR = 0.79 [95%CI 0.70 to 0.90] and United States HR = 0.90 [95%CI 0.88 to 0.93], pooled HR = 0.86 [95%CI 0.75 to 0.98]). Results for all models provided consistent effect estimates.

conclusionsAmong patients in Brazil and the United States, lower vitality score in the initial months of PD was independently associated with all-cause mortality.

Indexed as

Kidney Failure, ChronicPeritoneal DialysisAdultBrazilFatigueHumansProportional Hazards ModelsRetrospective StudiesRisk FactorsUnited States

Identifiers

PMID35749444
PMCPMC9231740
OpenAlexW4283466644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.